XBiotech Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 1.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 57.32M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Details
| Name | XBiotech Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 87 |
| Founded | 2005 |
| Ipo Date | 2015-04-15 |
| Ceo | Sushma Shivaswamy |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | CA98400H1029 |
| Cusip | 98400H102 |
| Cik | 0001626878 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| John Simard | Founder and Chairman |
| Angela Hu | Director of Finance |
Contact
| Address | 5217 Winnebago Lane, Austin, Texas 78744, United States |
| Phone | 512 386 2900 |
| Website | https://www.xbiotech.com |